Pharmaceuticals News

Source: Google
Pharmaceuticals News
  Titan Pharmaceuticals' (TTNP) CEO Sunil
Post AnalystTitan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q4 2016 Results - Earnings Call TranscriptSeeking AlphaGood afternoon. Thank you for holding and welcome to the Titan Pharmaceuticals full year and fourth quarter 2016 financial results conference call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session ...Titan Pharmaceuticals Reports Full Year And Fourth Quarter 2016 Financial ResultsPR Newswire (press release)Titan Pharmaceuticals Inc. (TTNP) Moves Lower on Volume Spike for March 16Equities.comTitan Pharmaceuticals reports 4Q lossYahoo Financeall 16 news articles »
Posted on 16 March 2017 | 7:50 pm
  Catabasis Pharmaceuticals' (CATB) CEO Jill
Catabasis Pharmaceuticals' (CATB) CEO Jill Milne on Q4 2016 Results - Earnings Call TranscriptSeeking AlphaGood day ladies and gentlemen and welcome to the Catabasis Pharmaceuticals Fourth Quarter and Full Year 2016 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions ...Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Corporate ...Business Wire (press release)all 2 news articles »
Posted on 16 March 2017 | 4:35 pm
  Why Aurinia Pharmaceuticals Shares Are on a
Motley FoolWhy Aurinia Pharmaceuticals Shares Are on a Wild Ride Lately ...Motley FoolPositive data for its lupus drug voclosporin sent shares soaring, only for a big stock offering to bring them back to earth.and more »
Posted on 16 March 2017 | 1:20 pm
  Marathon Pharma sells $89000 drug to NJ
Chicago Business JournalMarathon Pharma sells $89000 drug to NJ company amid pricing criticismChicago Business JournalMarathon Pharmaceuticals confirmed Thursday that it will sell its drug that costs U.S. patients $89,000 a year to treat muscular dystrophy. The Northbrook, Illinois-based Marathon will sell Emflaza to PTC Therapeutics (NASDAQ: PTCT) for $140 million in ...and more »
Posted on 16 March 2017 | 7:35 am
  Why Portola Pharmaceuticals Stock Is Already
The Cerbat GemWhy Portola Pharmaceuticals Stock Is Already Up an Eye-Popping 72% This YearMotley FoolPortola Pharmaceuticals (NASDAQ:PTLA) could win approvals from the Food and Drug Administration for two important new drugs in the coming year. Its drug betrixaban could become the first of a new class of drugs to be green-lighted for reducing the ...Portola Pharmaceuticals, Inc. (NASDAQ:PTLA): Important Trade and Target Levels To WatchPost AnalystInsider Trading at Portola Pharmaceuticals Inc?The Cerbat Gemall 26 news articles »
Posted on 16 March 2017 | 6:22 am
sponsored links
Source: Yahoo
Pharmaceuticals News
  NovaBay Pharmaceuticals to Offer Educational
At the April 19 workshop and dinner, nationally prominent eye experts will describe improvements in lid hygiene regimens made possible by NovaBay's Avenova lid cleanser EMERYVILLE, CA / ACCESSWIRE / April ...
Posted on 10 April 2015 | 9:25 am
  Adamas Pharmaceuticals Receives Orphan Drug
EMERYVILLE, Calif. -- Adamas Pharmaceuticals, Inc. today announced that the Food and Drug Administration (FDA) has granted orphan drug status to ADS-5102 for the treatment of levodopa-induced dyskinesia ...
Posted on 10 April 2015 | 5:30 am
  Reata Pharmaceuticals Receives Orphan Drug
Reata Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of breakthrough medicines for difficult-to-treat diseases, today announced that the FDA Office of Orphan Products Development ...
Posted on 10 April 2015 | 4:30 am
  Tokai Pharmaceuticals to Present at Upcoming
Tokai Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases
Posted on 10 April 2015 | 4:00 am
  Adamas Pharmaceuticals to Present at 2015
EMERYVILLE, Calif. -- Adamas Pharmaceuticals, Inc. today announced that Gregory T. Went, PhD., Chief Executive Officer, will present at the 2015 Needham Healthcare Conference in New York on Tuesday, April ...
Posted on 9 April 2015 | 1:01 pm
sponsored links
Source: Bing
Pharmaceuticals News
  Amgen wins approval for second biotech
Sanofi and partner Regeneron Pharmaceuticals Inc. won FDA approval for that drug last month. Analysts estimate between 8 million to 10 million patients are covered under the FDA-approved labeling for the drugs. But some experts worry the drugs could ...
Posted on 27 August 2015 | 10:18 pm
  Singapore manufacturing falls 6.1%
SINGAPORE: The Republic's industrial production fell year-on-year for the sixth straight month in July, hurt by lower output of electronics, pharmaceuticals and rigs, EDB reported on Wednesday (Aug 26). Production in the electronics cluster fell 5.8 per ...
Posted on 27 August 2015 | 9:52 pm
  New Data on Actelion Pulmonary Arterial
Actelion Pharmaceuticals Ltd recently announced in a press release that new data on its investigational drug selexipag (Uptravi®) and the approved macitentan (Opsumit®) for pulmonary arterial hypertension will be presented at the upcoming European ...
Posted on 27 August 2015 | 9:45 pm
  Teva Pharmaceutical Industries Ltd (ADR) Not
Teva has successfully switched patients to the 3x/week (40mg) from the once/daily (20mg)…” Teva continues to face generic competition on its once/daily (20mg) regimen from Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) and Sandoz, the generic drug unit of ...
Posted on 27 August 2015 | 9:12 pm
  ACADIA Pharmaceuticals Stock Rating
ACADIA Pharmaceuticals (NASDAQ:ACAD)‘s stock had its “outperform” rating reaffirmed by Cowen and Company in a note issued to investors on Friday, MarketBeat reports. They currently have a $50.00 price target on the biopharmaceutical company’s stock.
Posted on 27 August 2015 | 8:43 pm
sponsored links
Source: Newsvine
Pharmaceuticals News
  NJ drug company execs charged with insider
Executives at two leading drug companies were among six people arrested Monday and charged with insider trading in what federal prosecutors said was a five-year-long scheme that netted more than $1 million.
Posted on 19 November 2012 | 10:46 am
  AG: J&J must pay $52M in Pa. drug pricing
Johnson & Johnson must pay $52 million in damages and penalties after a Pennsylvania judge found the pharmaceutical company falsely reported the prices of its drugs.
Posted on 17 December 2010 | 3:19 pm
  Pfizer will buy King Pharmaceuticals for
Pfizer Inc. said Tuesday it will buy a company specializing in pain drugs in a $3.6 billion deal meant to shore up the portfolio of the world's largest drug company.
Posted on 11 October 2010 | 5:12 pm
  Endo Pharma paying $1.2 billion for
Drug developer Endo Pharmaceuticals Holdings Inc. said Tuesday it is buying Qualitest Pharmaceuticals for $1.2 billion in a move to diversify its business and strengthen its position in the generic and pain drug markets.
Posted on 28 September 2010 | 3:22 am
  Teva plans to appeal lawsuit verdict
Drugmaker Teva Pharmaceutical Industries Ltd. plans to appeal a $356 million Las Vegas district court verdict awarded to a plaintiff who says he contracted hepatitis C when one of Teva's drug vials was used by more than one patient.
Posted on 8 May 2010 | 8:56 am
Source: Twitter
Pharmaceuticals News
  BioPortfolio: aTyr Pharma Inc LIFE
BioPortfolio: aTyr Pharma Inc LIFE Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 10032017] Prices from... https://t.co/sPevYHX9yb
Posted on 26 March 2017 | 9:49 pm
  BioPortfolio: University of California
BioPortfolio: University of California Irvine Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 27022017]... https://t.co/wf3WSDuhXw
Posted on 26 March 2017 | 9:49 pm
  ParagDr: India - leading producer of generic
ParagDr: India - leading producer of generic pharmaceuticals, small cars & motorcycles ~ @jayantsinha *&@ #Reflecti*&@s https://t.co/ZR5WE9XAit
Posted on 26 March 2017 | 9:49 pm
  gunhalkar: .India - leading producer of
gunhalkar: .India - leading producer of generic pharmaceuticals, small cars & motorcycles ~ @jayantsinha !* #Reflecti!*s https://t.co/43IjJFGCu2
Posted on 26 March 2017 | 9:49 pm
  MergersBio: ARMO Biosciences Inc
MergersBio: ARMO Biosciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 23022017 Prices from USD $250 https://t.co/nvZTUwUqBE
Posted on 26 March 2017 | 9:49 pm
Source: Answers
Pharmaceuticals News
  Resolved Question: Are the pharmaceutical
Posted on 5 March 2016 | 2:50 pm
  Resolved Question: What are the duties of a
Posted on 25 September 2013 | 12:18 pm
  Resolved Question: What is the scope for
Posted on 6 July 2013 | 1:31 pm
  Resolved Question: Which is a bigger
These are my two agendas in an MUN as France. Pls help me decide which agenda to discuss first and with app. reasons! Any help would be appreciated!
Posted on 25 June 2013 | 10:46 pm
  Resolved Question: What is pharmaceutical
Which are the most intresting feilds in pharmaceutical science
Posted on 18 June 2013 | 5:50 am



HeadlineGrabber.com is a leading online Headline News aggregator that retrieves top feeds from the world's most respected web sources and integrates them into one convenient page packed with crispy fresh news articles structured around the subjects that interest you the most. Headline Grabber is the easiest way to get a balanced view on the News Headlines shaping your world. You can also follow us on twitter @HeadlineGrabber.

Copyright © Headline Grabber 2006 - 2017  | Contact Us | Disclaimer

( Processed in 2.91715 seconds )